MYD88 and diffuse large B-cell lymphoma: A recent study showed that BCL2 and MYC expression is significantly associated with MYD88 mutations in the ABC-DLBCL subgroup, however this study only looked at the MYD88 mutation status and no other genetic alterations in combination to BCL2 and MYC status30.